Picture of Hyperfine logo

HYPR — Hyperfine News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Hyperfine Inc reports results for the quarter ended June 30 - Earnings Summary

Hyperfine Inc reports results for the quarter ended June 30 - Earnings Summary
  • Hyperfine Inc HYPR.OQ reported a quarterly adjusted loss of 9 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -12 cents. The mean expectation of three analysts for the quarter was for a loss of 9 cents per share.

  • Revenue rose 44.8% to $3.90 million from a year ago; analysts expected $4.14 million.

  • Hyperfine Inc's reported EPS for the quarter was a loss of 9 cents​.

  • The company reported a quarterly loss of $9.3 million.

  • Hyperfine Inc shares had fallen by 27.4% this quarter and gained 0.1% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts was unchanged in the last three months.​

  • In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

  • Wall Street's median 12-month price target for Hyperfine Inc is $2.00, about 51% above its last closing price of $0.98

This summary was machine generated from LSEG data August 6 at 09:47 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Jun. 30 2026

-0.09

-0.09

Met

Mar. 31 2026

-0.09

-0.08

Beat

Dec. 31 2025

-0.08

-0.05

Beat

Sep. 30 2025

-0.10

-0.11

Missed

Recent news on Hyperfine

See all news